Advancements in Gene Therapy, Synthetic Biology, Diagnostic Assays, Imaging Tracers, and Biopharma

Share this:
Published: 18 Jan 2019

The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) provides recent advances across bioCDMO, synthetic biology, diagnostics and biopharma landscapes. The TOE provides analytical insights across Cyrus Bench, On/Off Synbio Switches, On-Point Solutions, Extremozymes, IQVIA Core, Homologus recombination, biopharmaceutical manufacturing, diagnostics, imaging, and cell therapy platforms. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Biotechnology, synthetic biology, on-point solutions, extremozymes, enzymes, homologus recombination, viral vector manufacturing, biomanufacturing, cell therapy, tau imaging, cancer screening, CAR-T, genomics, genes


Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..